According to Teva's presentation at RBC, you were right - revascor for CHF was highlighted as one of the most promising opportunities in the brand pipeline.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.